S100A9 and hepatocellular carcinoma: S100A9<sup>+</sup>CD14<sup>+</sup> monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function.